Monitor future Form 4 filings for any buy/sell activity by Martin Zuegel or his designated agents, as this may signal insider sentiment. The power of attorney setup suggests potential upcoming transactions, but no immediate trading impact is expected.
Price Chart
Executive Summary
Martin Zuegel, a reporting person at AC Immune SA, filed a Form 3 to report initial beneficial ownership of securities and appointed Christopher Roberts, Tim Kay, and Matthias Maurer as attorneys-in-fact to handle SEC filings on his behalf. The filing reflects standard initial ownership disclosure and administrative delegation of filing responsibilities.
Key Facts
- Martin Zuegel filed Form 3 to report initial beneficial ownership of AC Immune SA securities as of March 18, 2026.
- He holds 38,272 common shares directly and has options to purchase 52,577 shares at $1.84, vesting through June 17, 2026.
- Additionally, he holds 32,061 shares underlying restricted share units.
- Zuegel granted power of attorney to Christopher Roberts, Tim Kay, and Matthias Maurer to file Forms 3, 4, 5, and 144 on his behalf.
- The filing is routine and relates to compliance with Section 16 reporting requirements.
Financial Impact
No direct financial impact. Ownership includes 38,272 owned shares and options for 52,577 shares at $1.84, with additional 32,061 shares under restricted units.
Risk Factors
- Potential for future insider selling, especially after vesting dates in 2026.
- Lack of immediate transparency as filings may be executed by attorneys-in-fact without direct disclosure of intent.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0000950103-26-005191 |
| Document: 0000950103-26-005191-index-headers.html | 0000950103-26-005191 |
| Document: 0000950103-26-005191-index.html | 0000950103-26-005191 |
| Document: 0000950103-26-005191.txt | 0000950103-26-005191 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 16d ago | 3/A | $2.45 $2.40 | ▼ −2.04% | ▼ −2.03% | $2.42 (−1.22%) |
Oct 9, 2026 17d ago | 3 | $2.50 $2.45 | ▼ −2.00% | ▼ −1.94% | $2.42 (−3.20%) |
Oct 2, 2026 24d ago | 6-K | $2.73 $2.71 | ▼ −0.55% | ▼ −1.22% | $2.42 (−11.19%) |
Sep 23, 2026 4w ago | 6-K | $2.83 $2.66 | ▼ −6.01% | ▼ −5.92% | $2.42 (−14.49%) |
Sep 3, 2026 7w ago | 6-K | $2.93 $2.86 | ▼ −2.39% | ▼ −2.00% | $2.42 (−17.41%) |
Aug 20, 2026 9w ago | 6-K | $2.64 $2.90 | ▲ +9.85% | ▲ +9.44% | $2.42 (−8.33%) |
Aug 20, 2026 9w ago | Press Release | $2.64 $2.90 | ▲ +9.85% | ▲ +9.44% | $2.42 (−8.33%) |
Aug 11, 2026 10w ago | 6-K | $2.54 $2.62 | ▲ +3.15% | ▲ +2.90% | $2.42 (−4.72%) |
Aug 11, 2026 10w ago | Press Release | $2.54 $2.62 | ▲ +3.15% | ▲ +2.90% | $2.42 (−4.72%) |
Aug 5, 2026 11w ago | 6-K | $2.29 $2.32 | ▲ +1.31% | ▲ +1.47% | $2.42 (+5.68%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers